<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36813418</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>24</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1558-1942</ISSN><JournalIssue CitedMedium="Internet"><Volume>52</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Gastroenterology clinics of North America</Title><ISOAbbreviation>Gastroenterol Clin North Am</ISOAbbreviation></Journal><ArticleTitle>The Pathogenesis of Gastrointestinal, Hepatic, and Pancreatic Injury in Acute and Long Coronavirus Disease 2019 Infection.</ArticleTitle><Pagination><StartPage>1</StartPage><EndPage>11</EndPage><MedlinePgn>1-11</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.gtc.2022.12.001</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0889-8553(22)00091-7</ELocationID><Abstract><AbstractText>The gastrointestinal (GI) tract is targeted by severe acute respiratory syndrome coronavirus-2. The present review examines GI involvement in patients with long coronavirus disease and discusses the underlying pathophysiological mechanisms that include viral persistence, mucosal and systemic immune dysregulation, microbial dysbiosis, insulin resistance, and metabolic abnormalities. Due to the complex and potentially multifactorial nature of this syndrome, rigorous clinical definitions and pathophysiology-based therapeutic approaches are warranted.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Meringer</LastName><ForeName>Hadar</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Henry D. Janowitz Division of Gastroenterology, Department of Medicine; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, 1425 Madison Avenue, Icahn Building 11-02, New York, NY 10029, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Henry D. Janowitz Division of Gastroenterology, Department of Medicine; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, 1425 Madison Avenue, Icahn Building 11-02, New York, NY 10029, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mehandru</LastName><ForeName>Saurabh</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Henry D. Janowitz Division of Gastroenterology, Department of Medicine; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, 1425 Madison Avenue, Icahn Building 11-02, New York, NY 10029, USA. Electronic address: saurabh.mehandru@mssm.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Gastroenterol Clin North Am</MedlineTA><NlmUniqueID>8706257</NlmUniqueID><ISSNLinking>0889-8553</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D041981" MajorTopicYN="N">Gastrointestinal Tract</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008099" MajorTopicYN="N">Liver</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064806" MajorTopicYN="N">Dysbiosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005767" MajorTopicYN="Y">Gastrointestinal Diseases</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Gastrointestinal</Keyword><Keyword MajorTopicYN="N">Insulin resistance</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">MAFLD</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>22</Day><Hour>20</Hour><Minute>58</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>12</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36813418</ArticleId><ArticleId IdType="pmc">PMC9721275</ArticleId><ArticleId IdType="doi">10.1016/j.gtc.2022.12.001</ArticleId><ArticleId IdType="pii">S0889-8553(22)00091-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zhou P., Yang X.L., Wang X.G., et al. A&#xa0;pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270&#x2013;273.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7095418</ArticleId><ArticleId IdType="pubmed">32015507</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu R., Zhao X., Li J., et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 22 2020;395(10224):565&#x2013;574.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159086</ArticleId><ArticleId IdType="pubmed">32007145</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M., Kleine-Weber H., Schroeder S., et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020;181(2):271&#x2013;280.e8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim D., Lee J.Y., Yang J.S., et al. The Architecture of SARS-CoV-2 Transcriptome. Cell. 2020;181(4):914&#x2013;921.e10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7179501</ArticleId><ArticleId IdType="pubmed">32330414</ArticleId></ArticleIdList></Reference><Reference><Citation>Diamond M.S., Kanneganti T.D. Innate immunity: the first line of defense against SARS-CoV-2. Nat Immunol. 2022;23(2):165&#x2013;176.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8935980</ArticleId><ArticleId IdType="pubmed">35105981</ArticleId></ArticleIdList></Reference><Reference><Citation>Sette A., Crotty S. Adaptive immunity to SARS-CoV-2 and COVID-19. Cell. 2021;184(4):861&#x2013;880.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7803150</ArticleId><ArticleId IdType="pubmed">33497610</ArticleId></ArticleIdList></Reference><Reference><Citation>Merad M., Blish C.A., Sallusto F., et al. The immunology and immunopathology of COVID-19. Science. 2022;375(6585):1122&#x2013;1127.</Citation><ArticleIdList><ArticleId IdType="pubmed">35271343</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehandru S., Merad M. Pathological sequelae of long-haul COVID. Nat Immunol. 2022;23(2):194&#x2013;202.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9127978</ArticleId><ArticleId IdType="pubmed">35105985</ArticleId></ArticleIdList></Reference><Reference><Citation>Munblit D., O'Hara M.E., Akrami A., et al. Long COVID: aiming for a consensus. Lancet Respir Med. 2022;10(7):632&#x2013;634.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9067938</ArticleId><ArticleId IdType="pubmed">35525253</ArticleId></ArticleIdList></Reference><Reference><Citation>Meringer H., Mehandru S. Gastrointestinal post-acute COVID-19 syndrome. Nat Rev Gastroenterol Hepatol. 2022;19(6):345&#x2013;346.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8981882</ArticleId><ArticleId IdType="pubmed">35383321</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C., Darley D.R., Wilson D.B., et al. Immunological dysfunction persists for 8&#xa0;months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol. 2022;23(2):210&#x2013;216.</Citation><ArticleIdList><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y., Yuan D., Chen D.G., et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185(5):881&#x2013;895.e20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Cervia C., Zurbuchen Y., Taeschler P., et al. Immunoglobulin signature predicts risk of post-acute COVID-19 syndrome. Nat Commun. 2022;13(1):446.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8789854</ArticleId><ArticleId IdType="pubmed">35078982</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein J., Wood J., Jaycox J., et al. Distinguishing features of Long COVID identified through immune profiling. medRxiv. 2022 doi: 10.1101/2022.08.09.22278592.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.08.09.22278592</ArticleId><ArticleId IdType="pmc">PMC10620090</ArticleId><ArticleId IdType="pubmed">37748514</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A., Madhavan M.V., Sehgal K., et al. Extrapulmonary manifestations of COVID-19. Nat Med. 2020;26(7):1017&#x2013;1032.</Citation><ArticleIdList><ArticleId IdType="pubmed">32651579</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen N., Zhou M., Dong X., et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507&#x2013;513.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7135076</ArticleId><ArticleId IdType="pubmed">32007143</ArticleId></ArticleIdList></Reference><Reference><Citation>Redd W.D., Zhou J.C., Hathorn K.E., et al. Prevalence and characteristics of gastrointestinal symptoms in patients with severe acute respiratory syndrome coronavirus 2 infection in the united states: a multicenter cohort study. Gastroenterology. 2020;159(2):765&#x2013;767.e2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7195377</ArticleId><ArticleId IdType="pubmed">32333911</ArticleId></ArticleIdList></Reference><Reference><Citation>Sultan S., Altayar O., Siddique S.M., et al. AGA Institute Rapid Review of the Gastrointestinal and Liver Manifestations of COVID-19, Meta-Analysis of International Data, and Recommendations for the Consultative Management of Patients with COVID-19. Gastroenterology. 2020;159(1):320&#x2013;334.e27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7212965</ArticleId><ArticleId IdType="pubmed">32407808</ArticleId></ArticleIdList></Reference><Reference><Citation>Livanos A.E., Jha D., Cossarini F., et al. Intestinal Host Response to SARS-CoV-2 Infection and COVID-19 Outcomes in Patients With Gastrointestinal Symptoms. Gastroenterology. 2021;160(7):2435&#x2013;2450.e34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7931673</ArticleId><ArticleId IdType="pubmed">33676971</ArticleId></ArticleIdList></Reference><Reference><Citation>Hajifathalian K., Krisko T., Mehta A., et al. Gastrointestinal and Hepatic Manifestations of 2019 Novel Coronavirus Disease in a Large Cohort of Infected Patients From New York: Clinical Implications. Gastroenterology. 2020;159(3):1137&#x2013;1140.e2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7205652</ArticleId><ArticleId IdType="pubmed">32389667</ArticleId></ArticleIdList></Reference><Reference><Citation>Borobia A.M., Carcas A.J., Arnalich F., et al. A&#xa0;Cohort of Patients with COVID-19 in a Major Teaching Hospital in Europe. J&#xa0;Clin Med. 2020;9(6) doi: 10.3390/jcm9061733.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9061733</ArticleId><ArticleId IdType="pmc">PMC7356883</ArticleId><ArticleId IdType="pubmed">32512688</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen R., Yu Y.L., Li W., et al. Gastrointestinal symptoms associated with unfavorable prognosis of COVID-19 patients: a retrospective study. Front Med (Lausanne) 2020;7:608259.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7686879</ArticleId><ArticleId IdType="pubmed">33262996</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao R., Qiu Y., He J.S., et al. Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020;5(7):667&#x2013;678.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7217643</ArticleId><ArticleId IdType="pubmed">32405603</ArticleId></ArticleIdList></Reference><Reference><Citation>Su&#xe1;rez-Fari&#xf1;as M., Tokuyama M., Wei G., et al. Intestinal Inflammation Modulates the Expression of ACE2 and TMPRSS2 and Potentially Overlaps With the Pathogenesis of SARS-CoV-2-related Disease. Gastroenterology. 2021;160(1):287&#x2013;301.e20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7516468</ArticleId><ArticleId IdType="pubmed">32980345</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamers M.M., Beumer J., van der Vaart J., et al. SARS-CoV-2 productively infects human gut enterocytes. Science. 2020;369(6499):50&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7199907</ArticleId><ArticleId IdType="pubmed">32358202</ArticleId></ArticleIdList></Reference><Reference><Citation>Zang R., Gomez Castro M.F., McCune B.T., et al. TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes. Sci Immunol. 2020;5(47) doi: 10.1126/sciimmunol.abc3582.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abc3582</ArticleId><ArticleId IdType="pmc">PMC7285829</ArticleId><ArticleId IdType="pubmed">32404436</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung K.S., Hung I.F.N., Chan P.P.Y., et al. Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples From a Hong Kong Cohort: Systematic Review and Meta-analysis. Gastroenterology. 2020;159(1):81&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7194936</ArticleId><ArticleId IdType="pubmed">32251668</ArticleId></ArticleIdList></Reference><Reference><Citation>Blackett J.W., Wainberg M., Elkind M.S.V., et al. Potential Long Coronavirus Disease 2019 Gastrointestinal Symptoms 6 Months After Coronavirus Infection Are Associated With Mental Health Symptoms. Gastroenterology. 2022;162(2):648&#x2013;650.e2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8556689</ArticleId><ArticleId IdType="pubmed">34728186</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z., Xie Y., Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594(7862):259&#x2013;264.</Citation><ArticleIdList><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaebler C., Wang Z., Lorenzi J.C.C., et al. Evolution of antibody immunity to SARS-CoV-2. Nature. 2021;591(7851):639&#x2013;644.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8221082</ArticleId><ArticleId IdType="pubmed">33461210</ArticleId></ArticleIdList></Reference><Reference><Citation>Goh D., Lim J.C.T., Ferna&#xed;ndez S.B., et al. Case report: persistence of residual antigen and RNA of the SARS-CoV-2 virus in tissues of two patients with long COVID. Front Immunol. 2022;13:939989.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9483160</ArticleId><ArticleId IdType="pubmed">36131932</ArticleId></ArticleIdList></Reference><Reference><Citation>Zollner A., Koch R., Jukic A., et al. Postacute COVID-19 is Characterized by Gut Viral Antigen Persistence in Inflammatory Bowel Diseases. Gastroenterology. 2022;163(2):495&#x2013;506.e8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9057012</ArticleId><ArticleId IdType="pubmed">35508284</ArticleId></ArticleIdList></Reference><Reference><Citation>Meringer H., Tokuyama M., Tankelevich M., et al. 1161: Persistent immune cell abnormalities in the intestinal mucosa of patients after recovery from COVID-19 infection. Gastroenterology. 2022;162(7):S-277.</Citation></Reference><Reference><Citation>Liu Q., Mak J.W.Y., Su Q., et al. Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome. Gut. 2022;71(3):544&#x2013;552.</Citation><ArticleIdList><ArticleId IdType="pubmed">35082169</ArticleId></ArticleIdList></Reference><Reference><Citation>Blackett J.W., Li J., Jodorkovsky D., et al. Prevalence and risk factors for gastrointestinal symptoms after recovery from COVID-19. Neurogastroenterol Motil. 2022;34(3):e14251.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8646904</ArticleId><ArticleId IdType="pubmed">34468069</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai N.Y., Musser M.A., Pinho-Ribeiro F.A., et al. Gut-Innervating Nociceptor Neurons Regulate Peyer's Patch Microfold Cells and SFB Levels to Mediate Salmonella Host Defense. Cell. 2020;180(1):33&#x2013;49.e22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6954329</ArticleId><ArticleId IdType="pubmed">31813624</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahrends T., Aydin B., Matheis F., et al. Enteric pathogens induce tissue tolerance and prevent neuronal loss from subsequent infections. Cell. 2021;184(23):5715&#x2013;5727.e12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8595755</ArticleId><ArticleId IdType="pubmed">34717799</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei C., Wan L., Yan Q., et al. HDL-scavenger receptor B type 1 facilitates SARS-CoV-2 entry. Nat Metab. 2020;2(12):1391&#x2013;1400.</Citation><ArticleIdList><ArticleId IdType="pubmed">33244168</ArticleId></ArticleIdList></Reference><Reference><Citation>Wanner N., Andrieux G., Badia I.M.P., et al. Molecular consequences of SARS-CoV-2 liver tropism. Nat Metab. 2022;4(3):310&#x2013;319.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8964418</ArticleId><ArticleId IdType="pubmed">35347318</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang B., Zhang L., Wang Y., et al. Alterations in microbiota of patients with COVID-19: potential mechanisms and therapeutic interventions. Signal Transduct Target Ther. 2022;7(1):143.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9052735</ArticleId><ArticleId IdType="pubmed">35487886</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira-Junior A.S., Borgonovi T.F., De Salis L.V.V., et al. Detection of Intestinal Dysbiosis in Post-COVID-19 Patients One to Eight Months after Acute Disease Resolution. Int J Environ Res Public Health. 2022;19(16) doi: 10.3390/ijerph191610189.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph191610189</ArticleId><ArticleId IdType="pmc">PMC9408204</ArticleId><ArticleId IdType="pubmed">36011823</ArticleId></ArticleIdList></Reference><Reference><Citation>Clerbaux L.A., Fillipovska J., Mu&#xf1;oz A., et al. Mechanisms Leading to Gut Dysbiosis in COVID-19: Current Evidence and Uncertainties Based on Adverse Outcome Pathways. J&#xa0;Clin Med. 2022;11(18) doi: 10.3390/jcm11185400.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11185400</ArticleId><ArticleId IdType="pmc">PMC9505288</ArticleId><ArticleId IdType="pubmed">36143044</ArticleId></ArticleIdList></Reference><Reference><Citation>Dang A.T., Marsland B.J. Microbes, metabolites, and the gut-lung axis. Mucosal Immunol. 2019;12(4):843&#x2013;850.</Citation><ArticleIdList><ArticleId IdType="pubmed">30976087</ArticleId></ArticleIdList></Reference><Reference><Citation>Luci C., Bourinet M., Lecl&#xe8;re P.S., et al. Chronic Inflammation in Non-Alcoholic Steatohepatitis: Molecular Mechanisms and Therapeutic Strategies. Front Endocrinol (Lausanne) 2020;11:597648.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7771356</ArticleId><ArticleId IdType="pubmed">33384662</ArticleId></ArticleIdList></Reference><Reference><Citation>Queiroz M.A.F., Neves P., Lima S.S., et al. Cytokine Profiles Associated With Acute COVID-19 and Long COVID-19 Syndrome. Front Cell Infect Microbiol. 2022;12:922422.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9279918</ArticleId><ArticleId IdType="pubmed">35846757</ArticleId></ArticleIdList></Reference><Reference><Citation>Song Q., Zhang X. The Role of Gut-Liver Axis in Gut Microbiome Dysbiosis Associated NAFLD and NAFLD-HCC. Biomedicines. 2022;10(3) doi: 10.3390/biomedicines10030524.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines10030524</ArticleId><ArticleId IdType="pmc">PMC8945287</ArticleId><ArticleId IdType="pubmed">35327326</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez-Torres I., Guarner-Lans V., Soria-Castro E., et al. Alteration in the Lipid Profile and the Desaturases Activity in Patients With Severe Pneumonia by SARS-CoV-2. Front Physiol. 2021;12:667024.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8144632</ArticleId><ArticleId IdType="pubmed">34045976</ArticleId></ArticleIdList></Reference><Reference><Citation>Nie X., Qian L., Sun R., et al. Multi-organ proteomic landscape of COVID-19 autopsies. Cell. 2021;184(3):775&#x2013;791.e14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7794601</ArticleId><ArticleId IdType="pubmed">33503446</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrescu M., Vlaicu S.I., Cium&#x103;rnean L., et al. Chronic Inflammation-A Link between Nonalcoholic Fatty Liver Disease (NAFLD) and Dysfunctional Adipose Tissue. Medicina (Kaunas) 2022;58(5) doi: 10.3390/medicina58050641.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina58050641</ArticleId><ArticleId IdType="pmc">PMC9147364</ArticleId><ArticleId IdType="pubmed">35630058</ArticleId></ArticleIdList></Reference><Reference><Citation>Fignani D., Licata G., Brusco N., et al. SARS-CoV-2 Receptor Angiotensin I-Converting Enzyme Type 2 (ACE2) Is Expressed in Human Pancreatic &#x3b2;-Cells and in the Human Pancreas Microvasculature. Front Endocrinol (Lausanne) 2020;11:596898.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7691425</ArticleId><ArticleId IdType="pubmed">33281748</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaharuddin S.H., Wang V., Santos R.S., et al. Deleterious Effects of SARS-CoV-2 Infection on Human Pancreatic Cells. Front Cell Infect Microbiol. 2021;11:678482.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8285288</ArticleId><ArticleId IdType="pubmed">34282405</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller J.A., Gro&#xdf; R., Conzelmann C., et al. SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas. Nat Metab. 2021;3(2):149&#x2013;165.</Citation><ArticleIdList><ArticleId IdType="pubmed">33536639</ArticleId></ArticleIdList></Reference><Reference><Citation>Steenblock C., Richter S., Berger I., et al. Viral infiltration of pancreatic islets in patients with COVID-19. Nat Commun. 2021;12(1):3534.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8192507</ArticleId><ArticleId IdType="pubmed">34112801</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji N., Zhang M., Ren L., et al. SARS-CoV-2 in the pancreas and the impaired islet function in COVID-19 patients. Emerg Microbes Infect. 2022;11(1):1115&#x2013;1125.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9037197</ArticleId><ArticleId IdType="pubmed">35343389</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>